🚀 VC round data is live in beta, check it out!
Alzchem Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Alzchem Group and similar public comparables like FMC, Potasios De Chile, Saudi Kayan, Zeon and more.
Alzchem Group Overview
About Alzchem Group
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.
Founded
1908
HQ
Employees
1.7K
Website
Sectors
Financials (LTM)
EV
$2B
Alzchem Group Financials
Alzchem Group reported last 12-month revenue of $677M and EBITDA of $142M.
In the same LTM period, Alzchem Group generated $441M in gross profit, $142M in EBITDA, and $76M in net income.
Revenue (LTM)
Alzchem Group P&L
In the most recent fiscal year, Alzchem Group reported revenue of $663M and EBITDA of $141M.
Alzchem Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $677M | XXX | $663M | XXX | XXX | XXX |
| Gross Profit | $441M | XXX | $459M | XXX | XXX | XXX |
| Gross Margin | 65% | XXX | 69% | XXX | XXX | XXX |
| EBITDA | $142M | XXX | $141M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 21% | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 16% | XXX | XXX | XXX |
| Net Profit | $76M | XXX | $75M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 11% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Alzchem Group Stock Performance
Alzchem Group has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Alzchem Group's stock price is $210.68.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.0% | XXX | XXX | XXX | $7.42 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAlzchem Group Valuation Multiples
Alzchem Group trades at 3.1x EV/Revenue multiple, and 14.8x EV/EBITDA.
EV / Revenue (LTM)
Alzchem Group Financial Valuation Multiples
As of April 19, 2026, Alzchem Group has market cap of $2B and EV of $2B.
Equity research analysts estimate Alzchem Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Alzchem Group has a P/E ratio of 28.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 3.1x | XXX | 3.2x | XXX | XXX | XXX |
| EV/EBITDA | 14.8x | XXX | 14.9x | XXX | XXX | XXX |
| EV/EBIT | 19.5x | XXX | 19.1x | XXX | XXX | XXX |
| EV/Gross Profit | 4.8x | XXX | 4.6x | XXX | XXX | XXX |
| P/E | 28.0x | XXX | 28.4x | XXX | XXX | XXX |
| EV/FCF | 32.5x | XXX | 13.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Alzchem Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Alzchem Group Margins & Growth Rates
Alzchem Group's revenue in the last 12 month grew by 10%.
Alzchem Group's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Alzchem Group's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Alzchem Group's rule of X is 40% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Alzchem Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 21% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | 8% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 29% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 40% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 53% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Alzchem Group Public Comps
See public comps and valuation multiples for other Chemicals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Alzchem Group | XXX | XXX | XXX | XXX | XXX | XXX |
| FMC | XXX | XXX | XXX | XXX | XXX | XXX |
| Potasios De Chile | XXX | XXX | XXX | XXX | XXX | XXX |
| Saudi Kayan | XXX | XXX | XXX | XXX | XXX | XXX |
| Zeon | XXX | XXX | XXX | XXX | XXX | XXX |
| Robertet | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Alzchem Group M&A Activity
Alzchem Group acquired XXX companies to date.
Last acquisition by Alzchem Group was on XXXXXXXX, XXXXX. Alzchem Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Alzchem Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAlzchem Group Investment Activity
Alzchem Group invested in XXX companies to date.
Alzchem Group made its latest investment on XXXXXXXX, XXXXX. Alzchem Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Alzchem Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Alzchem Group
| When was Alzchem Group founded? | Alzchem Group was founded in 1908. |
| Where is Alzchem Group headquartered? | Alzchem Group is headquartered in Germany. |
| How many employees does Alzchem Group have? | As of today, Alzchem Group has over 1K employees. |
| Is Alzchem Group publicly listed? | Yes, Alzchem Group is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Alzchem Group? | Alzchem Group trades under ACT ticker. |
| When did Alzchem Group go public? | Alzchem Group went public in 2011. |
| Who are competitors of Alzchem Group? | Alzchem Group main competitors are FMC, Potasios De Chile, Saudi Kayan, Zeon. |
| What is the current market cap of Alzchem Group? | Alzchem Group's current market cap is $2B. |
| What is the current revenue of Alzchem Group? | Alzchem Group's last 12 months revenue is $677M. |
| What is the current revenue growth of Alzchem Group? | Alzchem Group revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Alzchem Group? | Current revenue multiple of Alzchem Group is 3.1x. |
| Is Alzchem Group profitable? | Yes, Alzchem Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Alzchem Group? | Alzchem Group's last 12 months EBITDA is $142M. |
| What is Alzchem Group's EBITDA margin? | Alzchem Group's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Alzchem Group? | Current EBITDA multiple of Alzchem Group is 14.8x. |
| What is the current FCF of Alzchem Group? | Alzchem Group's last 12 months FCF is $64M. |
| What is Alzchem Group's FCF margin? | Alzchem Group's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Alzchem Group? | Current FCF multiple of Alzchem Group is 32.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.